From July 1, 2023 to August 3, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 324,118 shares, representing 0.97% for KRW 2,997.54 million under the buyback announced on December 2, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,720 KRW | -1.21% | -6.84% | -34.85% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.85% | 137M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.